North America biomarkers market is expected to reach USD 16.72 billion by 2020 from USD 9.57 billion in 2015, growing at a CAGR of 11.80% during forecast period 2015-2020.
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/north-america-biomarkers-market-193/request-sample
- Services Growth Hormone Therapy
- Safety Biomarkers
- Efficacy Biomarkers
- Validation Biomarkers
- Diagnostics Development
- Drug Discovery and Development
- Personalised Medicine
- Disease Risk Assessment
- Other Applications
- Disease Indications
- Neurological Disorders
- Immunological Disorders
- Other Diseases
- Geographical Analysis
- North America
- United States
Growing number of cancer patients, rising adoption of advanced technologies (such as advanced high throughput technologies), increasing research to discover & develop the innovative biomarkers, and existence of huge number of pharmaceutical companies are driving the growth of biomarkers market in North America. In addition, growing funding from public & private organizations, presence of major market players, and increasing collaborations among the pharmaceutical companies are further propelling the growth of biomarkers market in North America. However, poor regulatory systems and reimbursement policies for the validation of biomarkers tests are restraining the growth of biomarkers market in North America.
On the basis of geographical areas, North America biomarkers market is segmented as U.S., and Canada.
The key players in biomarkers market include, Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases